Familial Episodic Pain Syndrome: Difference between revisions

From WikiMSK

mNo edit summary
No edit summary
Line 1: Line 1:
{{Condition}}
{{Authors}}
{{Condition
|inheritance=Heterozygous
|genetics=FEPS type I - TRPA1, activating <br>
FEPS type II - SCNA10A, activating<br>
FEPS type III - SCN11A (Nav1.9), activating
|clinicalfeatures=Familial episodic pain syndrome type I TRPA1 (TRPA1) Heterozygous, activating Onset at birth or in infancy; episodic chest or arm pain; triggers are hunger and cold
Familial episodic pain syndrome type III SCN11A (Nav1.9) Heterozygous, activating Onset in first decade; episodic hand and foot pain; triggers are intercurrent illness or exercise
}}
Familial episodic pain syndrome (FEPS) encompasses a group of non-inflammatory, paroxysmal pain syndromes primarily affecting the distal extremities. These syndromes can be classified into three types based on the pathogenic gene involved: FEPS1, caused by transient receptor potential cation channel (TRPA1) gene mutation; FEPS2, due to sodium voltage-gated channel alpha subunit 10A (SCN10A) gene mutation; and FEPS3, resulting from sodium voltage-gated channel alpha subunit 11A (SCN11A) gene mutation. FEPS3 is a particularly rare nerve ion channel disease that typically begins in infancy and is characterized by episodic pain in the distal limbs, with early detection being difficult due to limited symptom expression in infants and young children.
Familial episodic pain syndrome (FEPS) encompasses a group of non-inflammatory, paroxysmal pain syndromes primarily affecting the distal extremities. These syndromes can be classified into three types based on the pathogenic gene involved: FEPS1, caused by transient receptor potential cation channel (TRPA1) gene mutation; FEPS2, due to sodium voltage-gated channel alpha subunit 10A (SCN10A) gene mutation; and FEPS3, resulting from sodium voltage-gated channel alpha subunit 11A (SCN11A) gene mutation. FEPS3 is a particularly rare nerve ion channel disease that typically begins in infancy and is characterized by episodic pain in the distal limbs, with early detection being difficult due to limited symptom expression in infants and young children.


Line 5: Line 13:
[[Channelopathies and Chronic Pain]]
[[Channelopathies and Chronic Pain]]
[[Category:Genetic Disorders]]
[[Category:Genetic Disorders]]
{{References}}
{{Reliable sources}}

Revision as of 21:47, 30 March 2023


Familial Episodic Pain Syndrome
Inheritance Heterozygous
Genetics FEPS type I - TRPA1, activating

FEPS type II - SCNA10A, activating
FEPS type III - SCN11A (Nav1.9), activating

Clinical Features Familial episodic pain syndrome type I TRPA1 (TRPA1) Heterozygous, activating Onset at birth or in infancy; episodic chest or arm pain; triggers are hunger and cold

Familial episodic pain syndrome type III SCN11A (Nav1.9) Heterozygous, activating Onset in first decade; episodic hand and foot pain; triggers are intercurrent illness or exercise

Familial episodic pain syndrome (FEPS) encompasses a group of non-inflammatory, paroxysmal pain syndromes primarily affecting the distal extremities. These syndromes can be classified into three types based on the pathogenic gene involved: FEPS1, caused by transient receptor potential cation channel (TRPA1) gene mutation; FEPS2, due to sodium voltage-gated channel alpha subunit 10A (SCN10A) gene mutation; and FEPS3, resulting from sodium voltage-gated channel alpha subunit 11A (SCN11A) gene mutation. FEPS3 is a particularly rare nerve ion channel disease that typically begins in infancy and is characterized by episodic pain in the distal limbs, with early detection being difficult due to limited symptom expression in infants and young children.

See Also

Channelopathies and Chronic Pain

Literature Review